Implicity Raises €4M in Funding
Summary
Implicity , a Paris, France-based leader in remote monitoring of cardiac implantable electronic devices, raised €4m in funding. – Explore new markets, with the deployment of the first data center in the United States in 2019. – Accelerate the research and marketing of new “medical device” AI algorithms that improve the prognosis and follow-up of patients undergoing treatment while reducing the health resources required for this purpose. Created by Dr. Arnaud Rosier, cardiologist and AI researcher, this service allows remote management of alerts from connected devices from the five global manufacturers (Abbott, Biotronik, Boston Scientific, Medtronic and Microport) via a single, cohesive platform. After a year of deployment, the company is already the leader in France with more than 8,000 telemonitored patients daily.